Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results

Marker Therapeutics (MRKR) Misses Q1 EPS by 2c

May 12, 2021 4:32 PM EDT

Marker Therapeutics (NASDAQ: MRKR) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).

"We had a productive first quarter supported by our recently completed financing, strengthening our overall cash position and enabling continued growth and expansion of our Multi-TAA pipeline," said Peter L.... More